Simultaneously, HDAC6 has been shown to downregulate cyclin-dependent kinase inhibitor 1A (p21) expression by inhibiting SMAD2 phosphorylation, thereby attenuating TGF-β receptor signaling and facilitating tumor growth [81]. The gene discussed is CDKN1A; the disease is neoplasm.